ZHIYI PHARMACEUTICS
Founded in 2013, Zhiyi Bio focuses on the research and development of second-generation probiotics and Live Biotherapeutics. Based on the discovery of strains and drug development with independent intellectual property rights, a lot of innovative research has been carried out, and the “Know-How” from strains to drugs has been established, and the innovative live bacteria drug SK08 is about to enter the clinic. On this basis, Zhiyi will continue to strengthen the research and development of the relationship between human microbiome and disease, including microbial culture group and pathobionts research, target determination and separation of new functional strains.
ZHIYI PHARMACEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Guangzhou, Guangdong, China
Country:
China
Website Url:
http://www.zypharm.com.cn
Total Employee:
1+
Status:
Active
Contact:
020-82258826
Total Funding:
560 M CNY
Technology used in webpage:
Domain Not Resolving Euro Pound Sterling ASP.NET Japanese Yen Micro_httpd
Similar Organizations
Advanced Enzymes
Advanced Enzyme is a research driven company manufacturing enzymes and probiotics and dedicated to marketing eco-safe solutions.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aphea.Bio
Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.
Horizon Pharma
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
Kira Pharmaceuticals
Kira Pharmaceuticals is a Biotechnology Research Company.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
TauRx Pharmaceuticals
TauRx Pharmaceuticals is a life sciences company developing drugs and diagnostics for neurodegenerative diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Ye Wang Chief Executive Officer & Founder @ Zhiyi Pharmaceutics
Chief Executive Officer & Founder
Founder
Investors List
Airui Investment
Airui Investment investment in Series C - Zhiyi Pharmaceutics
Guangdong Technology Financial Group
Guangdong Technology Financial Group investment in Series C - Zhiyi Pharmaceutics
SDIC Venture Capital
SDIC Venture Capital investment in Series B - Zhiyi Pharmaceutics
Sinoking Capital
Sinoking Capital investment in Series B - Zhiyi Pharmaceutics
Kingsum Capital
Kingsum Capital investment in Series B - Zhiyi Pharmaceutics
SDIC Venture Capital
SDIC Venture Capital investment in Series B - Zhiyi Pharmaceutics
Korea Investment Holdings
Korea Investment Holdings investment in Series B - Zhiyi Pharmaceutics
Zhuhai Hengqin Lehong Investment Management
Zhuhai Hengqin Lehong Investment Management investment in Series B - Zhiyi Pharmaceutics
Shangdong Meiyu
Shangdong Meiyu investment in Series A - Zhiyi Pharmaceutics
Shenzhen Capital Group
Shenzhen Capital Group investment in Series A - Zhiyi Pharmaceutics
Official Site Inspections
http://www.zypharm.com.cn
- Host name: 103.236.254.229
- IP address: 103.236.254.229
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
